Immunotherapy of cytomegalovirus infection after stem-cell transplantation: a new option? (Q44636718)

4 December 2017

Immunotherapy of cytomegalovirus infection after stem-cell transplantation: a new option? (English)

1 reference

4 December 2017

0 references

1 reference

cytomegaloviral disease

1 reference

1

Hermann Einsele

1 reference

4 December 2017

Klaus Hamprecht

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

25 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585632

26 March 2024

number of pages

2

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0140673603146739?httpAccept=text/xml

1 reference

10.1016/S0140-6736(03)14673-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(03)14673-9

https://api.elsevier.com/content/article/PII:S0140673603146739?httpAccept=text/plain

26 March 2024

1 reference

10.1016/S0140-6736(03)14673-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(03)14673-9

26 March 2024

1 reference

4 December 2017

362

1 reference

4 December 2017

9393

1 reference

4 December 2017

1343-1344

1 reference

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Ganciclovir-resistant cytomegalovirus in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914673-9

7 January 2021

10.1016/S0140-6736(03)14673-9

Identifiers

DOI

1 reference

4 December 2017

1 reference